封面
市場調查報告書
商品編碼
1424470

多重檢測的全球市場:按產品類型、按技術、按應用、按最終用戶、按地區

Global Multiplex Assay Market, By Product, By Type, By Technology, By Application, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 180 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

多重檢測的全球市場規模預計將從2024年的 16.9 億美元增至2031年的 44 億美元,預測期內年複合成長率為 14.6%。

報告範圍 報告詳情
基準年 2023年 2023/2024年市場規模 16.9億美元
實際資料 2019年至2023年 預測期 2024-2031
預測期2023/2024~2030/2031年複合成長率: 14.60% 2030/2031價值預測 44億美元
圖 1.2024年依地區分類的多重檢測的全球市場佔有率(%)
全球多重檢測市場-IMG1

近年來,由於慢性病和感染疾病的全球盛行率不斷上升,多重檢測市場經歷了顯著成長。多重分析允許在一次測定中同時檢測多種分析物,提高診斷準確性和通量。這使得實驗室能夠簡化其測試流程,同時最大限度地降低營運成本。各種技術進步,包括微陣列和以微珠為基礎的技術,促進用於臨床診斷和研究應用的靈敏、高度特異性和高通量多重平台的開發。展望未來,越來越多的老年人口更容易患與老齡化相關的疾病,增加診斷測試的醫療保健支出以及精準醫療的擴展預計將為多重檢測市場的參與者提供利潤豐厚的機會。

市場動態:

多重分析市場是由個人化醫療需求不斷成長、蛋白質組學和基因組學領域活躍的研發活動以及多重分析在生物標記研究和臨床診斷中的應用不斷成長等因素所推動的。然而,檢測開發的複雜性和嚴格的法律規範構成了限制市場成長的挑戰。微射流和數位PCR技術的採用將促進高通量、低樣本量、可攜式多重平台的開發,並創造新的機會。缺乏熟練的專業人員和設備高成本也在一定程度上成為市場拓展的挑戰。

多重檢測技術的日益普及是市場的主要驅動力。多重檢測比傳統的單一檢測具有許多優勢,因為可以在單一實驗中同時分析多個標靶。多重檢測有可能以多種方式推動市場成長,包括同時測試多種分析物的能力,與手動測試相比,節省時間和精力。透過整合測試,多重檢測可以降低與試劑、消耗品和實驗室管理費用相關的整體成本。多重檢測是高通量篩檢的理想選擇,可用於大規模研究和臨床診斷。多重分析可以對有限的樣品量進行分析,並保留有價值的樣品,例如切片檢查或稀有細胞群。

例如,2021年6月,食品、環境、藥品和化妝品檢測領域的全球領導者Eurofins宣布推出 GSD NovaType III SARS-CoV-2 RT-PCR 檢測方法,該檢測方法專為快速檢測 SARS-CoV-2 變種而開發。該測定在單一反應中鑑定相關突變 E484Q、E484K 和 L452R,同時促進它們與 S 基因 E484 野生型突變體的區分。

研究的主要特點

  • 本報告對全球多重檢測市場進行了詳細分析,並提供了以2023年為基準年的預測期(2024-2031)的市場規模和年複合成長率(CAGR%)。
  • 強調了不同細分市場的潛在收益成長機會,並為該市場說明了一系列有吸引力的投資提案。
  • 提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景、主要企業採取的競爭策略等的主要考察。
  • 本報告根據公司亮點、產品系列、主要亮點,實績和策略等參數,介紹了全球多重檢測市場的主要企業。
  • 本報告的見解使行銷人員和公司負責人能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
  • 全球多重檢測市場報告迎合了該行業的各種相關人員,如投資者、供應商、產品製造商、經銷商、新進業者和財務分析師。
  • 透過用於分析全球多重檢測市場的各種策略矩陣,將促進相關人員的決策。

目錄

第1章 研究目的與前提

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • Coherent Opportunity Map(COM)

第3章 市場動態、法規及趨勢分析

  • 市場動態
  • 促進因素
  • 抑制因素
  • 機會
  • 影響分析
  • 主要亮點
  • 監管場景
  • 產品發布/核准
  • PEST分析
  • 波特的分析
  • 併購場景

第4章 冠狀病毒(COVID-19)大流行的影響

  • 新型冠狀病毒感染疾病(COVID-19)的流行病學
  • 供需面分析
  • 經濟影響

第5章 全球多重檢測市場,依產品,2019-2031年

  • 消耗品
  • 裝置
  • 軟體

第6章 全球多重檢測市場,依類型,2019-2031

  • 蛋白質多重檢測
  • 平面蛋白質測定
  • 以微珠為基礎的蛋白質檢測
  • 核酸多重檢測
  • 平面蛋白質測定
  • 以微珠為基礎的蛋白質檢測
  • 基於細胞的多重檢測

第7章 全球多重檢測市場,依技術,2019-2031

  • 流式細胞技術
  • 螢光偵測
  • 發光
  • 多重即時 PCR
  • 其他技術

第8章 全球多重檢測市場,依應用,2019-2031年

  • 研究與開發
  • 藥物研發發現與開發
  • 生物標記的發現與檢驗
  • 臨床診斷
  • 感染疾病
  • 癌症
  • 心血管疾病
  • 自體免疫疾病
  • 神經系統疾病
  • 代謝及內分泌疾病
  • 其他疾病

第9章 全球多重偵測市場,依最終使用者分類,2019-2031年

  • 製藥和生物技術公司
  • 醫院和實驗室
  • 研究和學術機構
  • 其他最終用戶

第10章 全球多重檢測市場,依地區,2019-2031

  • 北美洲
  • 美國
  • 加拿大
  • 歐洲
  • 德國
  • 英國
  • 西班牙
  • 法國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • ASEAN
  • 其他亞太地區
  • 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 海灣合作理事會國家
  • 以色列
  • 其他中東地區
  • 非洲
  • 南非
  • 北非
  • 中部非洲

第11章 競爭形勢

  • Luminex Corporation
  • Thermo Fisher Scientific, Inc.
  • Illumina, Inc.
  • Bio-Rad Laboratories, Inc.
  • Qiagen
  • Abcam Plc.
  • Becton, Dickinson and Company
  • Merck KGaA
  • Agilent Technologies
  • MESO SCALE DIAGNOSTICS, LLC.
  • Randox Laboratories Ltd.
  • Seegene Inc
  • Perkin Elmer Inc.
  • R&D Systems, Inc.
  • Advanced Cell Diagnostics, Inc.

第12章 章節

  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI6575

The global multiplex assay market size is expected to reach US$ 4.40 Bn by 2031, from US$ 1.69 Bn in 2024, at a CAGR of 14.6% during the forecast period.

Report Coverage Report Details
Base Year: 2023 Market Size in 2023/2024: US$ 1.69 Bn
Historical Data for: 2019 to 2023 Forecast Period: 2024-2031
Forecast Period 2023/2024 to 2030/2031 CAGR: 14.60% 2030/2031 Value Projection: US$ 4.40 Bn
Figure 1. Global Multiplex Assay Market Share (%), by Region, 2024
Global Multiplex Assay Market - IMG1

The multiplex assay market has been witnessing significant growth in the recent past on account of the rising incidence of chronic and infectious diseases globally. Multiplexing permits simultaneous detection of multiple analytes in a single assay run, which enhances diagnostic accuracy and throughput. It allows laboratories to streamline testing processes while minimizing operational costs. Various technological advancements including microarrays and bead-based techniques have facilitated the development of high-throughput multiplex platforms with high sensitivity and specificity for clinical diagnostics and research applications. Going forward, the growing geriatric population vulnerable to age-related illnesses, increasing healthcare expenditures on diagnostic testing, and expansion of precision medicine are expected to present lucrative opportunities for players in the multiplex assay market.

Market Dynamics:

The multiplex assay market is driven by factors such as growing demand for personalized medicine, robust R&D activity in the field of proteomics and genomics, and increasing applications of multiplex assays in biomarker research and clinical diagnostics. However, complexity of assay development and stringent regulatory framework are some challenges restraining the market growth. Adoption of microfluidics and digital PCR technologies create new opportunities by facilitating development of high-throughput, low sample volume, and portable multiplex platforms. Lack of skilled experts and high cost of instruments also challenge market expansion to some extent.

The growing adoption of multiplex assay techniques is a significant driver for the market. Multiplex assays offer numerous advantages over traditional singleplex assays by allowing the simultaneous analysis of multiple targets in a single experiment, which can drive the market growth in several ways such as multiplex assays can test for multiple analytes at once, saving time and labor compared to running. By consolidating tests, multiplex assays can reduce overall costs associated with reagents and consumables, as well as laboratory overhead. They are ideal for high-throughput screening, making them valuable in large-scale studies and clinical diagnostics. Multiplexing enables analysis from limited sample volumes, preserving precious samples like biopsy material or rare populations of cells.

For instance, in June 2021, Eurofins, the global leader in food, environment, pharmaceutical, and cosmetic product testing, announced the launch of GSD NovaType III SARS-CoV-2 RT-PCR assay, developed for the rapid detection of SARS-CoV-2 variants. The assay facilitates the identification of the relevant mutations E484Q, E484K, and L452R in one reaction combined with the simultaneous discrimination from the S gene E484 wildtype variant.

Key Features of the Study:

  • This report provides an in-depth analysis of the global multiplex assay market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global multiplex assay market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Luminex Corporation, Thermo Fisher Scientific, Inc., Illumina, Inc., Bio-Rad Laboratories, Inc., Qiagen, Abcam Plc., Becton, Dickinson and Company, Merck KGaA, Agilent Technologies, MESO SCALE DIAGNOSTICS, LLC., Randox Laboratories Ltd., Seegene Inc, Perkin Elmer Inc., R&D Systems, Inc., and Advanced Cell Diagnostics, Inc.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global multiplex assay market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global multiplex assay market

Detailed Segmentation:

  • By Product
    • Consumables
    • Instruments
    • Software
  • By Type
    • Protein Multiplex Assays
    • Planar Protein Assays
    • Bead-based Protein Assays
    • Nucleic Acid Multiplex Assays
    • Planar Protein Assays
    • Bead-based Protein Assays
    • Cell-based Multiplex Assays
  • By Technology
    • Flow Cytometry
    • Fluorescence Detection
    • Luminescence
    • Multiplex Real-time PCR
    • Other Technologies
  • By Application
    • Research & Development
    • Drug Discovery & Development
    • Biomarker Discovery & Validation
    • Clinical Diagnostics
    • Infectious Diseases
    • Cancer
    • Cardiovascular Diseases
    • Autoimmune Diseases
    • Nervous System Disorders
    • Metabolism & Endocrinology Disorders
    • Other Diseases
  • By End User
    • Pharmaceutical & Biotechnology Companies
    • Hospitals & Diagnostic laboratories
    • Research & Academic Institutes
    • Other End Users
  • By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Top Companies in the Multiplex Assay Market:
    • Luminex Corporation
    • Thermo Fisher Scientific, Inc.
    • Illumina, Inc.
    • Bio-Rad Laboratories, Inc.
    • Qiagen
    • Abcam Plc.
    • Becton, Dickinson and Company
    • Merck KGaA
    • Agilent Technologies
    • MESO SCALE DIAGNOSTICS, LLC.
    • Randox Laboratories Ltd.
    • Seegene Inc
    • Perkin Elmer Inc.
    • R&D Systems, Inc.
    • Advanced Cell Diagnostics, Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Multiplex Assay Market, By Product
    • Multiplex Assay Market, By Type
    • Multiplex Assay Market, By Technology
    • Multiplex Assay Market, By Application
    • Multiplex Assay Market, By End User
    • Multiplex Assay Market, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Driver
    • Advancing genomics and proteomics research
    • Increasing focus on precision medicine
    • Increasing product launches
  • Restraints
  • Opportunity
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Multiplex Assay Market, By Product, 2019-2031, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Consumables
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Instruments
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Software
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

6. Global Multiplex Assay Market, By Type, 2019-2031, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020-2031
    • Segment Trends
  • Protein Multiplex Assays
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Planar Protein Assays
  • Bead-based Protein Assays
  • Nucleic Acid Multiplex Assays
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Planar Protein Assays
  • Bead-based Protein Assays
  • Cell-based Multiplex Assays
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

7. Global Multiplex Assay Market, By Technology, 2019-2031, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020-2031
    • Segment Trends
  • Flow Cytometry
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Fluorescence Detection
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Luminescence
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Multiplex Real-time PCR
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Other Technologies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

8. Global Multiplex Assay Market, By Application, 2019-2031, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020-2031
    • Segment Trends
  • Research & Development
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Drug Discovery & Development
  • Biomarker Discovery & Validation
  • Clinical Diagnostics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Infectious Diseases
  • Cancer
  • Cardiovascular Diseases
  • Autoimmune Diseases
  • Nervous System Disorders
  • Metabolism & Endocrinology Disorders
  • Other Diseases

9. Global Multiplex Assay Market, By End User, 2019-2031, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020-2031
    • Segment Trends
  • Pharmaceutical & Biotechnology Companies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Hospitals & Diagnostic laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Research & Academic Institutes
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Other End Users
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

10. Global Multiplex Assay Market, By Region, 2019-2031, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Country, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, For Country, 2020 - 2031
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)Bn)
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/region, 2019-2031,(US$ Bn)
  • South Africa
  • North Africa
  • Central Africa

11. Competitive Landscape

  • Luminex Corporation
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Thermo Fisher Scientific, Inc.
  • Illumina, Inc.
  • Bio-Rad Laboratories, Inc.
  • Qiagen
  • Abcam Plc.
  • Becton, Dickinson and Company
  • Merck KGaA
  • Agilent Technologies
  • MESO SCALE DIAGNOSTICS, LLC.
  • Randox Laboratories Ltd.
  • Seegene Inc
  • Perkin Elmer Inc.
  • R&D Systems, Inc.
  • Advanced Cell Diagnostics, Inc.
  • Analyst Views

12. Section

  • Research Methodology
  • About us